HCA Healthcare, Inc. (LON:0J1R)
London
· Delayed Price · Currency is GBP · Price in USD 323.02
+3.89 (1.22%)
At close: Feb 20, 2025
HCA Healthcare Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 19, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 62,161 | 60,728 | 56,879 | 56,304 | 59,014 | 40,760 | Upgrade
|
| Market Cap Growth | 6.77% | 6.77% | 1.02% | -4.59% | 44.78% | 7.68% | Upgrade
|
| Enterprise Value | 98,763 | 96,572 | 90,608 | 90,284 | 85,188 | 61,446 | Upgrade
|
| Last Close Price | 250.00 | 238.97 | 211.19 | 194.42 | 184.69 | 116.48 | Upgrade
|
| PE Ratio | 13.51 | 13.20 | 13.82 | 12.02 | 11.49 | 14.82 | Upgrade
|
| PS Ratio | 1.08 | 1.08 | 1.12 | 1.13 | 1.36 | 1.08 | Upgrade
|
| PB Ratio | 136.99 | 136.99 | 68.35 | -929.32 | 53.67 | 19.24 | Upgrade
|
| P/FCF Ratio | 13.48 | 13.48 | 15.46 | 16.44 | 14.85 | 8.70 | Upgrade
|
| P/OCF Ratio | 7.23 | 7.23 | 7.68 | 7.96 | 8.92 | 6.03 | Upgrade
|
| EV/Sales Ratio | 1.77 | 1.71 | 1.78 | 1.81 | 1.96 | 1.63 | Upgrade
|
| EV/EBITDA Ratio | 8.36 | 8.72 | 9.08 | 9.05 | 9.21 | 8.40 | Upgrade
|
| EV/EBIT Ratio | 11.81 | 11.46 | 11.99 | 12.02 | 11.92 | 11.55 | Upgrade
|
| EV/FCF Ratio | 21.93 | 21.44 | 24.62 | 26.36 | 21.43 | 13.11 | Upgrade
|
| Debt / Equity Ratio | 81.51 | 81.51 | 39.49 | -550.68 | 24.67 | 11.45 | Upgrade
|
| Debt / EBITDA Ratio | 3.03 | 3.03 | 3.06 | 3.09 | 2.72 | 3.04 | Upgrade
|
| Debt / FCF Ratio | 8.02 | 8.02 | 8.93 | 9.74 | 6.83 | 5.17 | Upgrade
|
| Asset Turnover | 1.22 | 1.22 | 1.20 | 1.17 | 1.20 | 1.11 | Upgrade
|
| Inventory Turnover | 22.31 | 22.31 | 19.27 | 18.28 | 18.08 | 16.65 | Upgrade
|
| Quick Ratio | 0.84 | 0.84 | 0.87 | 1.00 | 1.01 | 1.03 | Upgrade
|
| Current Ratio | 1.08 | 1.08 | 1.18 | 1.38 | 1.41 | 1.42 | Upgrade
|
| Return on Equity (ROE) | 824.40% | 824.40% | 1234.25% | 965.25% | 352.48% | 377.05% | Upgrade
|
| Return on Assets (ROA) | 11.39% | 11.39% | 11.08% | 10.97% | 12.32% | 9.81% | Upgrade
|
| Return on Capital (ROIC) | 14.86% | 14.86% | 14.49% | 14.44% | 16.30% | 12.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 23.79% | 23.79% | 22.10% | 21.28% | 23.51% | 18.72% | Upgrade
|
| Earnings Yield | 7.40% | 7.58% | 7.24% | 8.32% | 8.71% | 6.75% | Upgrade
|
| FCF Yield | 7.25% | 7.42% | 6.47% | 6.08% | 6.74% | 11.50% | Upgrade
|
| Dividend Yield | 0.64% | 0.88% | 0.89% | 0.96% | 0.77% | 0.27% | Upgrade
|
| Payout Ratio | 11.98% | 11.98% | 12.61% | 11.57% | 8.97% | 4.08% | Upgrade
|
| Buyback Yield / Dilution | 5.28% | 5.28% | 6.19% | 10.37% | 4.32% | 1.33% | Upgrade
|
| Total Shareholder Return | 5.92% | 6.17% | 7.09% | 11.32% | 5.09% | 1.60% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.